• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study.结核病患者中耐多药结核病的危险因素:一项病例对照研究。
Infect Drug Resist. 2017 Mar 13;10:91-96. doi: 10.2147/IDR.S126274. eCollection 2017.
2
Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴圣彼得专科医院耐多药结核病患者的生存状况及死亡预测因素
Can J Infect Dis Med Microbiol. 2021 Sep 3;2021:6696199. doi: 10.1155/2021/6696199. eCollection 2021.
3
Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.埃塞俄比亚西北部耐多药结核病的危险因素:一项病例对照研究。
Transbound Emerg Dis. 2019 Jul;66(4):1611-1618. doi: 10.1111/tbed.13188. Epub 2019 Apr 15.
4
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.埃塞俄比亚西南部地区耐多药结核病的预测因素:一项病例对照研究。
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30. doi: 10.1186/s12941-018-0283-8.
5
Determinants of Multidrug-Resistant Infection: A Multicenter Study from Southern Ethiopia.多重耐药感染的决定因素:来自埃塞俄比亚南部的一项多中心研究
Infect Drug Resist. 2022 Jul 5;15:3523-3535. doi: 10.2147/IDR.S363628. eCollection 2022.
6
Attitudes of Healthcare Workers about Prevention and Control of Nosocomial Multidrug-Resistant Tuberculosis Infection in Two Top-Ranked Tuberculosis Specialized Public Hospitals of Ethiopia.埃塞俄比亚两家顶级结核病专科医院医护人员对医院内耐多药结核病感染防控的态度
Can J Infect Dis Med Microbiol. 2022 Dec 14;2022:5266347. doi: 10.1155/2022/5266347. eCollection 2022.
7
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.塞尔维亚肺结核患者中耐多药结核病的危险因素:一项病例对照研究。
BMC Public Health. 2018 Sep 12;18(1):1114. doi: 10.1186/s12889-018-6021-5.
8
Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.阿姆哈拉民族州耐多药结核病患者的风险因素。
Afr Health Sci. 2015 Jun;15(2):368-77. doi: 10.4314/ahs.v15i2.9.
9
Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.预测埃塞俄比亚奥罗米亚地区耐多药结核病患者不良治疗结局的时间的因素。
PLoS One. 2019 Oct 30;14(10):e0224025. doi: 10.1371/journal.pone.0224025. eCollection 2019.
10
Risk factors for mortality among multi-drug resistant tuberculosis patients in treatment follow-up centers, eastern Ethiopia: a retrospective follow-up study.治疗随访中心中耐多药结核病患者死亡的危险因素:一项回顾性随访研究,埃塞俄比亚东部。
Pan Afr Med J. 2022 Oct 13;43:78. doi: 10.11604/pamj.2022.43.78.31929. eCollection 2022.

引用本文的文献

1
Development and validation of a nomogram predicting multidrug-resistant tuberculosis risk in East China.华东地区预测耐多药结核病风险的列线图的开发与验证
PeerJ. 2025 Feb 27;13:e19112. doi: 10.7717/peerj.19112. eCollection 2025.
2
Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya.在肯尼亚西部进行的耐多药结核病监测研究中确定的疑似耐多药结核病患者中与结核耐药相关的因素。
J Clin Tuberc Other Mycobact Dis. 2024 Aug 2;37:100466. doi: 10.1016/j.jctube.2024.100466. eCollection 2024 Dec.
3
Body Mass Index a Forecast of Sputum Culture Conversion Among Drug-Resistant Tuberculosis Patients.体重指数是耐多药结核病患者痰培养转阴的一个预测指标。
Cureus. 2024 Jun 27;16(6):e63262. doi: 10.7759/cureus.63262. eCollection 2024 Jun.
4
Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.2015 年至 2021 年埃塞俄比亚西北部结核分枝杆菌和利福平耐药趋势:Xpert® MTB/RIF 检测结果。
BMC Infect Dis. 2024 Feb 22;24(1):238. doi: 10.1186/s12879-024-09135-0.
5
Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital.评估古卢地区转诊医院耐多药结核病(MDR-TB)相关的危险因素。
Afr Health Sci. 2023 Sep;23(3):343-357. doi: 10.4314/ahs.v23i3.41.
6
Distribution of multi-drug resistant tuberculosis in Ekiti and Ondo states, Nigeria.尼日利亚埃基蒂州和翁多州耐多药结核病的分布情况。
New Microbes New Infect. 2023 Oct 31;55:101192. doi: 10.1016/j.nmni.2023.101192. eCollection 2023 Oct.
7
Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.加纳一所教学医院耐多药结核病的预测因素:病例对照研究。
PLoS One. 2023 Nov 29;18(11):e0294928. doi: 10.1371/journal.pone.0294928. eCollection 2023.
8
Investigating the intensity of social contacts associated with tuberculosis: a weighted networks model.调查与肺结核相关的社会接触强度:加权网络模型。
BMC Pulm Med. 2023 Jun 26;23(1):226. doi: 10.1186/s12890-023-02519-z.
9
Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia.埃塞俄比亚阿姆哈拉西北部地区结核/艾滋病毒合并感染特征及耐多药结核病模式
Infect Drug Resist. 2023 Jun 16;16:3829-3845. doi: 10.2147/IDR.S412951. eCollection 2023.
10
Characteristics of Previous Tuberculosis Treatment History in Patients with Treatment Failure and the Impact on Acquired Drug-Resistant Tuberculosis.治疗失败患者既往结核病治疗史的特征及其对获得性耐药结核病的影响
Antibiotics (Basel). 2023 Mar 16;12(3):598. doi: 10.3390/antibiotics12030598.

本文引用的文献

1
Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.印度一家三级转诊医院中耐多药和广泛耐药结核病的危险因素。
PLoS One. 2010 Mar 4;5(3):e9527. doi: 10.1371/journal.pone.0009527.
2
Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.西非布基纳法索四个中心耐多药结核病的危险因素
Microb Drug Resist. 2009 Sep;15(3):217-21. doi: 10.1089/mdr.2009.0906.
3
Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.圣彼得结核病专科医院复诊患者中的耐多药结核病情况。
Ethiop Med J. 2008 Jul;46(3):219-25.
4
Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.格鲁吉亚共和国耐多药结核病的患病率及危险因素:一项基于人群的研究。
Int J Tuberc Lung Dis. 2009 Jan;13(1):68-73.
5
Tb drug resistance: is it really a threat to Africa?结核病耐药性:它真的对非洲构成威胁吗?
Ethiop Med J. 2007 Oct;45(4):399-404.
6
Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey.南非耐多药结核病的决定因素:一项全国性调查的结果
S Afr Med J. 2007 Nov;97(11 Pt 3):1120-8.
7
Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital.一家三级医院中结核分枝杆菌的多重耐药情况
J Natl Med Assoc. 2007 Oct;99(10):1185-9.
8
Tuberculosis drug resistance and HIV infection, the Netherlands.荷兰的结核病耐药性与艾滋病毒感染
Emerg Infect Dis. 2007 May;13(5):776-8. doi: 10.3201/eid1305.060334.
9
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.卢旺达肺结核患者耐药性全国调查结果。
Int J Tuberc Lung Dis. 2007 Feb;11(2):189-94.
10
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.耐多药结核病:流行病学、预防与治疗
Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005.

结核病患者中耐多药结核病的危险因素:一项病例对照研究。

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study.

作者信息

Workicho Abdulhalik, Kassahun Wondwosen, Alemseged Fessahaye

机构信息

Department of Epidemiology, College of Health Sciences, Jimma University, Jimma, Ethiopia.

出版信息

Infect Drug Resist. 2017 Mar 13;10:91-96. doi: 10.2147/IDR.S126274. eCollection 2017.

DOI:10.2147/IDR.S126274
PMID:28331350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5357068/
Abstract

BACKGROUND

Multidrug-resistant tuberculosis (MDR-TB) did not receive major attention until recently in sub-Saharan Africa where the tuberculosis incidence and risk factors are highest. Factors leading to development of drug resistance need to be understood to develop appropriate control strategies for national programs. The objective of this study was to identify the risk factors for MDR-TB among tuberculosis patients.

METHODS

A case-control study was conducted to assess sociodemographic, behavioral and clinical risk factors using a structured questionnaire and clinical record reviewing. The data were entered and analyzed using SPSS windows version 16. Descriptive analysis was done to generate summary values for the variables and those significant variables in the bivariate analysis at -value less than 0.25 were entered to multivariable logistic regression to identify independent determinants. Statistical significance was declared at -value less than or equal to 0.05.

RESULTS

A total of 90 cases and 90 controls were included in the study. Age of respondents (adjusted odds ratio [AOR] =7; 95% confidence interval [CI]: 2.6-24.5), living in a household with only one room (AOR=5; 95%CI: 1.68-15.38), history of previous treatment (AOR=21; 95% CI: 17.8-28) and being HIV infected (AOR=3.1; 95%CI: 1.02-9.4) were found to be independent predictors of MDR-TB.

CONCLUSION

In light of these findings, the strategies in controlling MDR-TB should emphasize on patients with HIV coinfection, young patients, those who have a history of previous treatment, and those living in crowded places.

摘要

背景

耐多药结核病(MDR-TB)直到最近才在撒哈拉以南非洲受到主要关注,而该地区结核病发病率和风险因素最高。为国家项目制定适当的控制策略,需要了解导致耐药性产生的因素。本研究的目的是确定结核病患者中耐多药结核病的风险因素。

方法

进行了一项病例对照研究,使用结构化问卷和临床记录回顾来评估社会人口统计学、行为和临床风险因素。数据使用SPSS 16.0 for Windows版本录入和分析。进行描述性分析以生成变量的汇总值,双变量分析中P值小于0.25的显著变量被纳入多变量逻辑回归以确定独立决定因素。P值小于或等于0.05时具有统计学意义。

结果

该研究共纳入90例病例和90例对照。受访者年龄(调整比值比[AOR]=7;95%置信区间[CI]:2.6-24.5)、居住在单间家庭(AOR=5;95%CI:1.68-15.38)、既往治疗史(AOR=21;95%CI:17.8-28)和感染艾滋病毒(AOR=3.1;95%CI:1.02-9.4)被发现是耐多药结核病的独立预测因素。

结论

鉴于这些发现,控制耐多药结核病的策略应强调合并感染艾滋病毒的患者、年轻患者、有既往治疗史的患者以及居住在拥挤场所的患者。